内視鏡逆行性胆管膵管造影の世界市場の規模は、2023年に19億8,000万ドルと推定され、2024年から2030年にかけて8.3%のCAGRで成長すると予想されます。この成長の主な推進要因は、胆石、膵炎、胆管閉塞などの膵臓および胆道疾患の発生率の上昇にあり、内視鏡的逆行性胆管膵臓造影 (ERCP) の需要が高まっています。人口の高齢化やライフスタイルの変化に伴い、これらの疾患の有病率が増加し、市場の成長を促進すると予想されます。2024年2月に発表されたClinical Gastroenterology and Hepatologyの研究によると、胆石の有病率は世界全体で推定6%であり、女性と南米でより高い割合が観察されています。調査によると、胆石の発生率は予測期間中に急激に上昇すると予想され、それによってERCP手順の需要が高まります。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Procedure
1.2.3. End use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Procedure outlook
2.2.3. End use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Endoscopic Retrograde Cholangiopancreatography Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Endoscopic Retrograde Cholangiopancreatography Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Endoscopic Retrograde Cholangiopancreatography Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Endoscopic Retrograde Cholangiopancreatography Market: Product Movement Analysis
4.3. Endoscopic Retrograde Cholangiopancreatography Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Endoscopes
4.5.1. Endoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Endotherapy Devices
4.6.1. Endotherapy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. Sphincterotomes
4.6.2.1. Sphincterotomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. Lithotripter
4.6.3.1. Lithotripter Market Revenue Estimates and Fo recasts, 2018 - 2030 (USD Million)
4.6.4. Stents
4.6.4.1. Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.5. Cannulas
4.6.5.1. Cannulas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.6. Forceps
4.6.6.1. Forceps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.7. Snares
4.6.7.1. Snares Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.8. Catheters
4.6.8.1. Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.9. Guiding Wires
4.6.9.1. Guiding Wires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.10. Balloons
4.6.10.1. Balloons Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.11. Baskets
4.6.11.1. Baskets Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Visualization Systems
4.7.1. Visualization Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Energy Devices
4.8.1. Energy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Others
4.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Endoscopic Retrograde Cholangiopancreatography Market: Procedure Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Endoscopic Retrograde Cholangiopancreatography Market: Procedure Movement Analysis
5.3. Endoscopic Retrograde Cholangiopancreatography Market by Procedure Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Biliary Sphincterotomy
5.5.1. Biliary Sphincterotomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Biliary Stenting
5.6.1. Biliary Stenting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Biliary Dilatation
5.7.1. Biliary Dilatation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Pancreatic Sphincterotomy
5.8.1. Pancreatic Sphincterotomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Pancreatic Duct Stenting
5.9.1. Pancreatic Duct Stenting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Pancreatic Duct Dilation
5.10.1. Pancreatic Duct Dilation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Endoscopic Retrograde Cholangiopancreatography Market: End use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Endoscopic Retrograde Cholangiopancreatography Market: End use Movement Analysis
6.3. Endoscopic Retrograde Cholangiopancreatography Market by End use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals
6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Outpatient Facilities
6.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Endoscopic Retrograde Cholangiopancreatography Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Regional Endoscopic Retrograde Cholangiopancreatography Market movement analysis
7.3. Endoscopic Retrograde Cholangiopancreatography Market: Regional Estimates & Trend Analysis by Technology & End use
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. North America
7.5.1. North America Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement scenario
7.5.2.5. U.S. Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Canada
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Canada Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement scenario
7.5.4.5. Mexico Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Europe
7.5.6. Europe Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. UK
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement scenario
7.5.7.5. UK Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Germany
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement scenario
7.5.8.5. Germany Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. France
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement scenario
7.5.9.5. France Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.10. Italy
7.5.10.1. Key Country Dynamics
7.5.10.2. Competitive Scenario
7.5.10.3. Regulatory Framework
7.5.10.4. Reimbursement scenario
7.5.10.5. Italy Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.11. Spain
7.5.11.1. Key Country Dynamics
7.5.11.2. Competitive Scenario
7.5.11.3. Regulatory Framework
7.5.11.4. Reimbursement scenario
7.5.11.5. Spain Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.12. Denmark
7.5.12.1. Key Country Dynamics
7.5.12.2. Competitive Scenario
7.5.12.3. Regulatory Framework
7.5.12.4. Reimbursement scenario
7.5.12.5. Denmark Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.13. Sweden
7.5.13.1. Key Country Dynamics
7.5.13.2. Competitive Scenario
7.5.13.3. Regulatory Framework
7.5.13.4. Reimbursement scenario
7.5.13.5. Sweden Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.14. Norway
7.5.14.1. Key Country Dynamics
7.5.14.2. Competitive Scenario
7.5.14.3. Regulatory Framework
7.5.14.4. Reimbursement scenario
7.5.14.5. Norway Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement scenario
7.6.2.5. Japan Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement scenario
7.6.3.5. China Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement scenario
7.6.4.5. India Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement scenario
7.6.5.5. South Korea Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Australia Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement scenario
7.6.7.5. Thailand Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Brazil Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement scenario
7.7.3.5. Argentina Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement scenario
7.8.2.5. South Africa Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement scenario
7.8.3.5. Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement scenario
7.8.4.5. UAE Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Kuwait Endoscopic Retrograde Cholangiopancreatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Olympus Corporation
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. CONMED Corporation
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Boston Scientific Corporation
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Medtronic PLC
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Telemed System, Inc.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. AMBU, Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. FUJIFILM Holdings Corporation
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Hobbs Medical, Inc.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Cook Group
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Streis PLC
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. HOYA Group
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. Karl Storz SE & Co. KG
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 4 Global Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 5 Global Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 6 North America Endoscopic Retrograde Cholangiopancreatography market, by region, 2018 - 2030 (USD Million)
Table 7 North America Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 8 North America Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 9 North America Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 12 U.S. Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 13 Mexico Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 14 Mexico Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 15 Mexico Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million
Table 16 Canada Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 17 Canada Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 18 Canada Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
Table 20 Europe Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 21 Europe Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 22 Europe Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 23 UK Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 24 UK Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 25 UK Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 26 Germany Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 27 Germany Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 28 Germany Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 29 France Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 30 France Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 31 France Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 33 Italy Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 34 Italy Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 35 Spain Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 36 Spain Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 37 Spain Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 38 Norway Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 39 Norway Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 40 Norway Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 41 Sweden Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 42 Sweden Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 43 Sweden Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 44 Denmark Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 45 Denmark Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 46 Denmark Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 51 Japan Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 52 Japan Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 53 Japan Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 54 China Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 55 China Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 56 China Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 57 India Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 58 India Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 59 India Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 60 Australia Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 61 Australia Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 62 Australia Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 63 South Korea Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 64 South Korea Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 65 South Korea Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 66 Thailand Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 67 Thailand Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 68 Thailand Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 69 Latin America Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 71 Latin America Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 72 Latin America Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 73 Brazil Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 74 Brazil Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 75 Brazil Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 76 Argentina Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 77 Argentina Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 78 Argentina Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 83 South Africa Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 84 South Africa Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 85 South Africa Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 89 UAE Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 90 UAE Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 91 UAE Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 92 Kuwait Endoscopic Retrograde Cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 93 Kuwait Endoscopic Retrograde Cholangiopancreatography market, by Procedure, 2018 - 2030 (USD Million)
Table 94 Kuwait Endoscopic Retrograde Cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Endoscopic Retrograde Cholangiopancreatography market segmentation
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Endoscopic Retrograde Cholangiopancreatography market, product outlook key takeaways (USD Million)
Fig. 12 Endoscopes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 13 Endotherapy devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Sphincterotomes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Lithotripter market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Stents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Cannulas market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Forceps market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Snares market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Catheters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Guiding wires market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Balloons market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Baskets market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Visualization systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Energy devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Endoscopic Retrograde Cholangiopancreatography market, Procedure outlook key takeaways (USD Million)
Fig. 28 Endoscopic Retrograde Cholangiopancreatography market: Procedure movement analysis 2023 & 2030 (USD Million)
Fig. 29 Biliary sphincterotomy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Biliary stenting market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Biliary dilatation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Pancreatic sphincterotomy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Pancreatic duct stenting market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Pancreatic duct dilation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Endoscopic Retrograde Cholangiopancreatography market, end use outlook key takeaways (USD Million)
Fig. 36 Endoscopic Retrograde Cholangiopancreatography market: end use movement analysis 2023 & 2030 (USD Million)
Fig. 37 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Outpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Endoscopic Retrograde Cholangiopancreatography market: Regional key takeaways (USD Million)
Fig. 40 Endoscopic Retrograde Cholangiopancreatography market: regional outlook, 2023 & 2030, USD Million
Fig. 41 North America Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 U.S. Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Canada Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Mexico Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Europe Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 UK Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Germany Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 France Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Spain Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Italy Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Sweden Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Norway Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Denmark Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Asia Pacific Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 China Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Japan Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 India Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 South Korea Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Australia Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Thailand Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Latin America Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Brazil Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Argentina Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 South Africa Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 UAE Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Kuwait Endoscopic Retrograde Cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 List of key emerging company’s/technology disruptors/innovators